Chronic wound and ear infections are often difficult to treat because bacteria form protective biofilms that reduce the effectiveness of conventional antimicrobials. In collaboration with Lixa, this project is developing novel sol-gel formulations that combine antibiofilm and resistance-breaking compounds with existing antibiotics to improve treatment outcomes. By enhancing drug delivery and targeting persistent biofilm-associated infections, the project aims to provide safer, longer-lasting therapies for veterinary applications while helping to slow the development of antimicrobial resistance.